ArticleHaematologica2025

High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children's Oncology Group AALL1231 trial.

Margot S F Roeten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.